title: [Focus: fulminant and subfulminant hepatic insufficiency].
authors.affiliation: Département de médecine, Hôpital des Cadolles, Neuchâtel.
authors.forename: M
authors.initials: M
authors.lastname: Fellay
authors.forename: R
authors.initials: R
authors.lastname: Kehtari
mesh_terms: D000111:Acetylcysteine / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications / Q000209:etiology; D003131:Combined Modality Therapy; D003422:Critical Care; D006501:Hepatic Encephalopathy / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D006525:Hepatitis, Viral, Human / Q000150:complications; D006801:Humans; D000860:Hypoxia / Q000150:complications; D017114:Liver Failure, Acute / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D016031:Liver Transplantation; D011379:Prognosis
chemical_list: D000111:Acetylcysteine
vernacular_title: Mise au point: insuffisance hépatique fulminante et subfulminante.